Weight loss drugs slash risk of 4 types of cancer by 50% or more, study finds

Scientists have found that GLP-1 medications, such as Ozempic, and Wegovy, is linked to a decrease in the overall risk of developing obesity-related cancers, especially with colorectal, pancreatic, and endometrial cancers.